Clinical Trial Search

Primary: Elicited Imitation Memory Task - Short Delay Memory Measure: 6 Months — 0.252; 0.183 change in percentage correct

Primary: Change in the Alcohol Use Disorders Identification Test (AUDIT) Score Over Time — -5.8; -4.0 score on a scale

Primary: Number of Participants With Negative Urinalysis for Alcohol Metabolite (EtG) — 44 Participants

Primary: BrainHQ Learning Rate — 867.6; 861.7 milliseconds

Primary: Pittsburg Side-Effects Scale: Motor Tics — 0.15; 0.20; 0.31; 0.27 units on a scale

Primary: Alcohol Use — 86; 82; 131; 137 Participants

Primary: Parent Awareness of Own Emotion Score for Sadness at Baseline and Immediate Post-intervention (8 Weeks) — 32.73; 32.37; 32.20; 32.47 score on a scale — p=.523

Primary: Eyberg Child Behavior Inventory at Baseline and 3-Month Follow-Up — 69.31; 65.62 score on a scale

Primary: Urine Ethylglucuronide (EtG) Testing — 0 Participants

Primary: Change in Mean Knowledge About FASD From Baseline to 6 Weeks — 15.50; 17.14; 16.57; 17.14 units on a scale — p=0.587

Primary: Attachment Classification — 0; 0; 0; 0 participants

Primary: Mean Change in Subjective Well-being From Baseline to 6-week Follow-up on the Personal Well-Being Index - Intellectual Disability Version — 3.51; 3.59 units on a scale…

Primary: Clinical Global Impression- Severity Scale (CGI-S) — 7.0 units on a scale

Primary: Side Effects of Choline Bitartrate — 8; 10; 8; 9 participants

Primary: Eyberg Child Behavior Inventory - Intensity at Baseline and 12-week Follow-Up — 68.33; 69.13; 68.40; 64.47 T-score — p=.602

Primary: Fetal Heart Rate — 142.34 beats per minute

Primary: Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation — 13; 6; 8; 21 Participants

Primary: Change in Bile Salt Metabolism (C4 )Levels to Determine Effect of FXR

Primary: Change in Blood Oxygenation Level Dependent (BOLD) Activation in the Amygdala During "Win" Monetary Incentive Delay (MID) Task Between Placebo and Study Medication…

Primary: Number of Participants Reporting Risky Alcohol Use — 99; 86; 60; 48 Participants

Primary: Visual Analog Scale of Craving to Drink at 1 Week Following Administration of Fenofibrate or Placebo During the Double-Blind Period — 8.94; 10.37; 9.83; 11.03 units on a…

Primary: Change From Baseline in Behavioral Symptoms of Fragile X Syndrome Using the Aberrant Behavior Checklist-Community Edition (ABC-CFX) Total Score in Stratum I Patients…

Primary: California Verbal Learning Test II (CVLT2) Trial 1-5 Free Recall Total Raw Score — 34.0; 33.5 score on a scale

Primary: The Number of Subjects With Unexpected Serious Adverse Events. — 0; 0; 0 Participants

Primary: Gestational Weight Gain (GWG) — 12; 10 kg — p=0.01

Primary: Level of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to…

Primary: Change in Mean Value of Parental Pro-sipping Beliefs Score — 0.13; 0.08 score on a scale

Primary: Change in EEG Relative Gamma Power — 0.0024; -0.0077; -0.0039; 0.0019 percent of power in gamma frequencies

Primary: Number of Drinks Felt Consumed at Baseline — 0; 0; 0; 0 drinks felt consumed

Primary: Bioavailability — 1.95; 1.80; 3.00; 0.80 mol%